Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(4-TrifluoroMethoxyphenyl)phenol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

173025-79-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 173025-79-1 Structure
  • Basic information

    1. Product Name: 4-(4-TrifluoroMethoxyphenyl)phenol
    2. Synonyms: 4-(4-TrifluoroMethoxyphenyl)phenol;4'-(Trifluoromethoxy)-[1,1'-biphenyl]-4-ol
    3. CAS NO:173025-79-1
    4. Molecular Formula: C13H9F3O2
    5. Molecular Weight: 254.2045696
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 173025-79-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-(4-TrifluoroMethoxyphenyl)phenol(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-(4-TrifluoroMethoxyphenyl)phenol(173025-79-1)
    11. EPA Substance Registry System: 4-(4-TrifluoroMethoxyphenyl)phenol(173025-79-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 173025-79-1(Hazardous Substances Data)

173025-79-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 173025-79-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,0,2 and 5 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 173025-79:
(8*1)+(7*7)+(6*3)+(5*0)+(4*2)+(3*5)+(2*7)+(1*9)=121
121 % 10 = 1
So 173025-79-1 is a valid CAS Registry Number.

173025-79-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[4-(trifluoromethoxy)phenyl]phenol

1.2 Other means of identification

Product number -
Other names 4-trifluoromethoxy-4'-hydroxybiphenyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:173025-79-1 SDS

173025-79-1Relevant articles and documents

Exploiting Coupling of Boronic Acids with Triols for a pH-Dependent click-Declick Chemistry

Golovanov, Ivan S.,Mazeina, Galina S.,Nelyubina, Yulia V.,Novikov, Roman A.,Mazur, Anton S.,Britvin, Sergey N.,Tartakovsky, Vladimir A.,Ioffe, Sema L.,Sukhorukov, Alexey Yu.

, p. 9756 - 9773 (2018)

Click-like condensation of boronic acids with specifically designed triols (boronate-triol coupling) produces stable diamantane adducts in aqueous medium, which can be controllably cleaved to initial components under acidic conditions or by using boric acid as a chemical trigger. This novel click-declick strategy allows for the creation of temporary covalent connections between two or more modular units, which was demonstrated by the synthesis of new fluorophore-labeled natural molecules (peptides, steroids), supramolecular assemblies, modified polymers, boronic acid scavengers, solid-supported organocatalysts, biodegradable COF-like materials, and dynamic combinatorial libraries.

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 00472; 00473; 00788; 00789, (2021/01/22)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 00514; 00515; 00516; 00830; 00831; 00832, (2019/07/17)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

Photopolymerizable oxetane derivative and liquid-crystal composition containing it

-

, (2008/06/13)

Provided are a liquid-crystal compound and a liquid-crystal composition containing the compound, of which the advantages are that they show nematic hybrid orientation on a rubbed TAC substrate, they are polymerizable in open air and they readily give a po

ERbeta ligands. Part 1: the discovery of ERbeta selective ligands which embrace the 4-hydroxy-biphenyl template.

Edsall Jr., Richard J,Harris, Heather A,Manas, Eric S,Mewshaw, Richard E

, p. 3457 - 3474 (2007/10/03)

The synthesis and structure-activity relationships of a series of simple biphenyls is described. Optimization of the 4-hydroxy-biphenyl template led to compounds with ERbeta selectivity on the order of 20-70-fold.

Ionic Liquid Acceleration of Solid-Phase Suzuki-Miyaura Cross-Coupling Reactions

Revell, Jefferson D.,Ganesan

, p. 3071 - 3073 (2007/10/03)

(Equation Presented) Room-temperature ionic liquids promote various transition metal-catalyzed reactions in the solution phase. Here, for the first time, we show that these effects are translatable to solid-phase reactions. The Suzuki-Miyaura cross-coupli

Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770

Curtin, Michael L.,Florjancic, Alan S.,Heyman,Michaelides, Michael R.,Garland, Robert B.,Holms, James H.,Steinman, Douglas H.,Dellaria, Joseph F.,Gong, Jane,Wada, Carol K.,Guo, Yan,Elmore, Ildiko B.,Tapang, Paul,Albert, Daniel H.,Magoc, Terrance J.,Marcotte, Patrick A.,Bouska, Jennifer J.,Goodfellow, Carole L.,Bauch, Joy L.,Marsh, Kennan C.,Morgan, Douglas W.,Davidsen, Steven K.

, p. 1557 - 1560 (2007/10/03)

Modification of the biphenyl portion of MMP inhibitor 2a gave analogue 2i which is greater than 1000-fold selective against MMP-2 versus MMP-1. The stereospecific synthesis of both enantiomers of 2i was achieved beginning with (S)- or (R)-benzyl glycidyl ether. The (S)-enantiomer, 11 (ABT-770), is orally bioavailable and efficacious in an in vivo model of tumor growth. Elsevier Science Ltd. All rights reserved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 173025-79-1